Martel, A.; Gastaud, L.; Bonnetaud, C.; Nahon-Esteve, S.; Washetine, K.; Bordone, O.; Salah, M.; Tanga, V.; Fayada, J.; Lespinet, V.;
et al. Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank. Cancers 2023, 15, 2372.
https://doi.org/10.3390/cancers15082372
AMA Style
Martel A, Gastaud L, Bonnetaud C, Nahon-Esteve S, Washetine K, Bordone O, Salah M, Tanga V, Fayada J, Lespinet V,
et al. Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank. Cancers. 2023; 15(8):2372.
https://doi.org/10.3390/cancers15082372
Chicago/Turabian Style
Martel, Arnaud, Lauris Gastaud, Christelle Bonnetaud, Sacha Nahon-Esteve, Kevin Washetine, Olivier Bordone, Myriam Salah, Virginie Tanga, Julien Fayada, Virginie Lespinet,
and et al. 2023. "Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank" Cancers 15, no. 8: 2372.
https://doi.org/10.3390/cancers15082372
APA Style
Martel, A., Gastaud, L., Bonnetaud, C., Nahon-Esteve, S., Washetine, K., Bordone, O., Salah, M., Tanga, V., Fayada, J., Lespinet, V., Allegra, M., Lalvee, S., Zahaf, K., Baillif, S., Bertolotto, C., Mograbi, B., Lassalle, S., & Hofman, P.
(2023). Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank. Cancers, 15(8), 2372.
https://doi.org/10.3390/cancers15082372
